NCT06493734 - Stereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 1, 2027

Study Completion Date

March 1, 2028

Conditions

Klatskin Tumor

Interventions

RADIATION

Stereotactic body radiation therapy

SBRT will be delivered in 15 fractions of 4 to 4.5Gy (risk-adapted), one fraction each weekday for 3 weeks.

Trial Locations (8)

NOT_YET_RECRUITING

University Hospital Brussels / Jules Bordet Institute, Brussels

NOT_YET_RECRUITING

Antwerp University Hospital / Sint-Augustinus Gasthuiszusters, Wilrijk

RECRUITING

Radboud University Medical Center, Nijmegen

RECRUITING

Maastricht University Medical Center+ / Maastro Clinic Maastricht, Maastricht

RECRUITING

Amsterdam University Medical Center, Amsterdam

RECRUITING

University Medical Center Groningen, Groningen

RECRUITING

Erasmus MC, Rotterdam

RECRUITING

University Medical Center Utrecht, Utrecht